MyAverix Finance
ST · Healthcare
Lipigon Pharmaceuticals AB (LPGO)
Biotechnology
Lipigon Pharmaceuticals AB (LPGO) is listed on ST in the Healthcare sector. Industry: Biotechnology. As of 2026-05-24, reported market cap is $908,900, P/E ratio is 25.00, net margin is 0.0%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for LPGO
Lipigon Pharmaceuticals AB (LPGO) — FAQ
What is Lipigon Pharmaceuticals AB's market cap?
Lipigon Pharmaceuticals AB (LPGO) has a reported market cap of $908,900 (data as of 2026-05-24).
What is LPGO's P/E ratio?
The price-to-earnings (P/E) ratio for Lipigon Pharmaceuticals AB (LPGO) is 25.00 (data as of 2026-05-24).
Does Lipigon Pharmaceuticals AB pay a dividend?
Dividend yield is not available in the current snapshot for Lipigon Pharmaceuticals AB (LPGO). Check the MyAverix Finance app for the latest dividend data.
What sector is Lipigon Pharmaceuticals AB in?
Lipigon Pharmaceuticals AB (LPGO) is classified in the Healthcare sector (Biotechnology industry).
What exchange is LPGO listed on?
LPGO is listed on ST.
What is Lipigon Pharmaceuticals AB's net margin?
Lipigon Pharmaceuticals AB (LPGO) reports a net margin of 0.0% (data as of 2026-05-24).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.